Prism Medico and Pharmacy last traded at ₹32.09 (2026-10-13). Over the past month the stock moved +7.6%, three months the stock moved +13.4%, year the stock moved +87.1%. Its closing range over 52 weeks is ₹16.91 – ₹32.77, with the latest close 2.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1985, Prism Medico & Pharmacy Ltd manufactures, trades, and distributes chemicals, medicines, pharmaceuticals, cosmetics, and related products[1]
Business Overview:[1] PMPL deals in chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals, pesticides, dyes, soaps, oils, perfumes, cosmetics, patent medicines, etc.
In the latest quarter (Jun 2026), Prism Medico and Pharmacy reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.06 crore (-109.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.15 | – | -0.06 | -0.04 |
| Mar 2026 | 0.28 | -0.12 | -42.86 | -0.24 | -0.40 |
| Dec 2025 | 0.07 | -0.02 | -28.57 | -0.01 | -0.02 |
| Sep 2025 | 0.50 | -0.10 | -20.00 | -0.08 | -0.13 |
| Jun 2025 | 1.59 | 0.65 | 40.88 | 0.66 | 1.09 |
| Mar 2025 | 0.07 | 0.01 | 14.29 | 0.04 | 0.07 |
| Dec 2024 | 0.21 | -0.01 | -4.76 | -0.01 | -0.02 |
| Sep 2024 | 0.29 | 0.01 | 3.45 | 0.01 | 0.02 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +866.7% | -92.4% | -53.3% | +2550.0% | +72.4% | -66.7% | +300.0% | -100.0% |
| Operating profit growth | – | -105.3% | – | – | -1100.0% | – | -1300.0% | -123.1% |
| Net profit growth | – | -105.3% | – | – | -900.0% | – | -700.0% | -109.1% |
| EPS growth | – | -106.5% | – | – | -750.0% | – | -671.4% | -103.7% |
| OPM % | 3.5% | -4.8% | 14.3% | 40.9% | -20.0% | -28.6% | -42.9% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Prism Medico and Pharmacy reported sales of ₹2.44 crore (+287.3%) and net profit of ₹0.32 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2.44 | 0.40 | 16.39 | 0.32 | 0.53 |
| Mar 2025 | 0.63 | -0.08 | -12.70 | -0.05 | -0.08 |
| Mar 2024 | 2.93 | -0.13 | -4.44 | -0.02 | -0.03 |
| Mar 2023 | 1.27 | -0.10 | -7.87 | -0.08 | -0.13 |
| Mar 2022 | 8.44 | -0.49 | -5.81 | -0.37 | -0.61 |
| Mar 2021 | 16.76 | -0.16 | -0.95 | -0.13 | -0.21 |
| Mar 2020 | 26.89 | -0.05 | -0.19 | -0.05 | -0.08 |
| Mar 2019 | 36.31 | 0.33 | 0.91 | 0.37 | 0.61 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +73.2% | -25.9% | -37.7% | -49.6% | -85.0% | +130.7% | -78.5% | +287.3% |
| Operating profit growth | +230.0% | -115.2% | – | – | – | – | – | – |
| Net profit growth | – | -113.5% | – | – | – | – | – | – |
| EPS growth | – | -113.1% | – | – | – | – | – | – |
| OPM % | 0.9% | -0.2% | -1.0% | -5.8% | -7.9% | -4.4% | -12.7% | 16.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Prism Medico and Pharmacy.
Get Free AI Stock Analysis FREE →Prism Medico & Pharmacy reports standalone net loss of Rs 0.06 crore in the June 2026 quarter - Business Standard
Prism Medico and Pharmacy shares were last quoted at ₹32.09 (+5.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Prism Medico and Pharmacy has a price-to-earnings (P/E) ratio of -97.93 and a price-to-book (P/B) ratio of 1.34. The industry P/E is 24.58.
The 52-week high of Prism Medico and Pharmacy is ₹34.49 and the 52-week low is ₹15.51.
The market capitalisation of Prism Medico and Pharmacy is about ₹38.52 crore.
In the latest quarter (Jun 2026), Prism Medico and Pharmacy reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.06 crore (-109.1%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Prism Medico and Pharmacy has a 3-year ROE of 1.00%, 3-year profit growth of 82.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 29.98% of Prism Medico and Pharmacy.
Prism Medico and Pharmacy belongs to the Finance - Investment sector.